• Borg Neville posted an update 9 hours, 29 minutes ago

    Low-dose, weekly cisplatin (40 mg/m

    ) regimens are currently utilized at Eskenazi Health in Indianapolis, Indiana for the treatment of head and neck cancer due to enhanced tolerability. This retrospective analysis analyzes the incidence, severity, and risk factors for AKI in patients who received this regimen.

    A retrospective chart r…[Read more]

  • Borg Neville posted an update 9 hours, 29 minutes ago

    Low-dose, weekly cisplatin (40 mg/m

    ) regimens are currently utilized at Eskenazi Health in Indianapolis, Indiana for the treatment of head and neck cancer due to enhanced tolerability. This retrospective analysis analyzes the incidence, severity, and risk factors for AKI in patients who received this regimen.

    A retrospective chart r…[Read more]

  • Borg Neville posted an update 9 hours, 30 minutes ago

    Low-dose, weekly cisplatin (40 mg/m

    ) regimens are currently utilized at Eskenazi Health in Indianapolis, Indiana for the treatment of head and neck cancer due to enhanced tolerability. This retrospective analysis analyzes the incidence, severity, and risk factors for AKI in patients who received this regimen.

    A retrospective chart r…[Read more]

  • Borg Neville posted an update 9 hours, 30 minutes ago

    Low-dose, weekly cisplatin (40 mg/m

    ) regimens are currently utilized at Eskenazi Health in Indianapolis, Indiana for the treatment of head and neck cancer due to enhanced tolerability. This retrospective analysis analyzes the incidence, severity, and risk factors for AKI in patients who received this regimen.

    A retrospective chart r…[Read more]

  • Borg Neville posted an update 4 days, 5 hours ago

    Having MM was identified as an independent prognostic factor in a multivariate analysis with adjusted hazard ratios of 0.28 (95% confidence interval, 0.09-0.83).

    For cancer patients with ONJ related to zoledronic acid, patients with MM endure a worse treatment outcome.

    For cancer patients with ONJ related to zoledronic acid, patients…[Read more]

  • Borg Neville posted an update 4 days, 5 hours ago

    Having MM was identified as an independent prognostic factor in a multivariate analysis with adjusted hazard ratios of 0.28 (95% confidence interval, 0.09-0.83).

    For cancer patients with ONJ related to zoledronic acid, patients with MM endure a worse treatment outcome.

    For cancer patients with ONJ related to zoledronic acid, patients…[Read more]

  • Borg Neville became a registered member 4 days, 5 hours ago